Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7365)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 15, 2020 (publication date) through Dec 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo QY, Lu B, Guo ZH, Feng ZQ, Yuan YY, Jin XG, Zang P, Gu P, Shao JQ. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes. World J Diabetes 2020; 11(11): 489-500 [PMID: 33269061 DOI: 10.4239/wjd.v11.i11.489] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v11/i11/489.htm |
| Number | Citing Articles |
| 1 |
Trisha Shang, Jennifer Y. Zhang, Andreas Thomas, Mark A. Arnold, Beatrice N. Vetter, Lutz Heinemann, David C. Klonoff. Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies. Journal of Diabetes Science and Technology 2022; 16(1): 168 doi: 10.1177/19322968211007212
|
| 2 |
Zhou-qin Feng, Qing-yu Guo, Wei Wang, Yan-yu Yuan, Xu-guang Jin, Hui Zhou, Jun Liu, Hai-yan Lei, Xin-yi Yang, Jun Liu, Bin Lu, Jia-qing Shao, Ping Gu. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes. Diabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00739-z
|
| 3 |
Hoda Gad, Einas Elgassim, Ibrahim Mohammed, Ahmad Yaser Alhaddad, Hussein Ahmed Hussein Zaky Aly, John-John Cabibihan, Abdulaziz Al-Ali, Kishor Kumar Sadasivuni, Aliyaa Haji, Neila Lamine, Adnan Khan, Ioannis N Petropoulos, Georgios Ponirakis, Alise Kalteniece, Maryam Ferdousi, Shazli Azmi, Uazman Alam, Wajeeha Abuhelaiqa, Amin Jayyousi, Dabia AlMohanadi, Khaled Baagar, Rayaz A Malik. Continuous glucose monitoring reveals a novel association between duration and severity of hypoglycemia, and small nerve fiber injury in patients with diabetes. Endocrine Connections 2022; 11(12) doi: 10.1530/EC-22-0352
|
| 4 |
Ming Wang, Niuniu Chen, Yaxin Wang, Jiaying Ni, Jingyi Lu, Weijing Zhao, Yating Cui, Ronghui Du, Wei Zhu, Jian Zhou. Association of sudomotor dysfunction with risk of diabetic retinopathy in patients with type 2 diabetes. Endocrine 2024; 84(3): 951 doi: 10.1007/s12020-023-03682-3
|
| 5 |
Rishi Raj, Rahul Mishra, Nivedita Jha, Vivek Joshi, Ricardo Correa, Philip A Kern. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Research & Care 2022; 10(1): e002573 doi: 10.1136/bmjdrc-2021-002573
|
| 6 |
Evanthia Gouveri, Nikolaos Papanas. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review. Diabetes Therapy 2022; 13(5): 931 doi: 10.1007/s13300-022-01257-5
|
| 7 |
Ayman Al Hayek, Wael M Alzahrani, Samia H Sobki, Abdulghani H Al-Saeed, Mohamed Al Dawish. Comparison of Point-of-Care and Laboratory Glycated Hemoglobin A1c and Its Relationship to Time-in-Range and Glucose Variability: A Real-World Study. Cureus 2023; doi: 10.7759/cureus.33416
|
| 8 |
Melanie A. Jackson, Andrew Ahmann, Viral N. Shah. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2021; 23(S1): S-27 doi: 10.1089/dia.2021.0007
|
| 9 |
Bedia Fulya Calikoglu, Selda Celik, Cemile Idiz, Elif Bagdemir, Halim Issever, Jean-Henri Calvet, Ilhan Satman. Electrochemical skin conductances values and clinical factors affecting sudomotor dysfunction in patients with prediabetes, type 1 diabetes, and type 2 diabetes: A single center experience. Primary Care Diabetes 2023; 17(5): 499 doi: 10.1016/j.pcd.2023.06.002
|
| 10 |
Ramzi A. Ajjan, Tadej Battelino, Xavier Cos, Stefano Del Prato, Jean-Christophe Philips, Laurent Meyer, Jochen Seufert, Samuel Seidu. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nature Reviews Endocrinology 2024; 20(7): 426 doi: 10.1038/s41574-024-00973-1
|
| 11 |
Wei Cao, Jing Zou, Ming Gao, Jianv Huang, Yangyang Li, Na Li, Li Qian, Ying Zhang, Minjun Ji, Yu Liu. A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-β test. Journal of Diabetes and its Complications 2024; 38(10): 108831 doi: 10.1016/j.jdiacomp.2024.108831
|
| 12 |
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Haipeng Xiao, Yanbing Li. Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of Diabetes 2023; 15(2): 133 doi: 10.1111/1753-0407.13355
|